Q2 2025 saw a slight sales decline but improved operating results, with global orders and a major UK framework deal. A successful rights issue strengthened liquidity, and the company is well-positioned for growth amid favorable market trends and upcoming trade events.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.